One third of the variability in HDL-cholesterol level in a large dyslipidaemic population is predicted by age, sex and triglyceridaemia: The Paris La Pitié Study

Current Medical Research and Opinion

Volumn 22, Issue 6, 2006, Pages 1149-1160

  Hansel, Boris ^a,b   Kontush, Anatol ^b   Giral, Philippe ^a   Bonnefont Rousselot, Dominique ^a   Chapman, M John ^b   Bruckert, Eric ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Determinants; Dyslipidaemic patients; HDL C; Low HDL C phenotype; Prevalence

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ABSTINENCE; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHENOTYPE; PREDICTION; PREVALENCE; SEX DIFFERENCE; SMOKING; UNIVARIATE ANALYSIS; WAIST CIRCUMFERENCE;

ADULT; AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SEX FACTORS;

EID: 33745714067     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X104821     Document Type: Article

References (56)

1. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52
2. UK HDL-C Consensus Group. Role of fibrates in reducing coronary risk: a UK consensus. Curr Med Res Opin 2004;20:241-7
3. Sacks FM. The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations. Am J Cardiol 2002;90:139-43
4. Aguilar-Salinas CA, Olaiz G, Valles V, et al. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res 2001;42:1298-307
5. Assmann G, Schulte H, von Eckardstein A, Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996;124(Suppl):S11-S20
6. Schaefer EJ, Lamon-Fava S, Ordovas JM, et al. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res 1994;35:871-82
7. Rubins HB, Robins SJ, Collins D, et al. Distribution of lipids in 8500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group. Am J Cardiol 1995;75:1196-201
8. Asztalos BF, Cupples LA, Demissie S, et al. High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 2004;24:2181-7
9. Bates HM. Prevalence of hyperlipidemia in a large sample population. J Cardiovasc Pharmacol 1982;4(Suppl 2):S196-S200
10. Meigs JB, Wilson PW, Nathan DM, et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003;52:2160-7
11. Balkau B, Vernay M, Mhamdi L, et al. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab 2003;29:526-32
12. Verschuren WM, Boerma GJ, Kromhout D. Total and HDL-cholesterol in The Netherlands: 1987-1992. Levels and changes over time in relation to age, gender and educational level. Int J Epidemiol 1994;23:948-56
13. Bruckert E PR, McCoy F, et al. Defining the prevalence of low HDL-C in a European cohort of dyslipidaemic patients. Eur Heart J Suppl 2005;7:23-6
14. Adult Treatment Panel III. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. J Am Med Assoc 2001;285:2486-97
15. Egloff M, Leglise D, Duvillard L, et al. Multicenter evaluation on different analyzers of three methods for direct HDL-cholesterol assay. Ann Biol Clin (Paris) 1999;57:561-72
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
17. Bayer P, Veinberg F, Couderc R, et al. Multicenter evaluation of four homogenous LDL-cholesterol assays. Ann Biol Clin (Paris). 2005;63:27-41
18. Albers JJ, Marcovina SM, Kennedy H. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. II. Evaluation and selection of candidate reference materials. Clin Chem 1992;38:658-62
19. Blackburn R, Giral P, Bruckert E, et al. Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects. Arterioscler Thromb Vasc Biol 2001;21:1962-8
20. Lamarche B, Despres JP, Moorjani S, et al. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Quebec cardiovascular study. Atherosclerosis 1996;119:235-45
21. Goldberg DI, Beltz WF, Pittman RC. Evaluation of pathways for the cellular uptake of high density lipoprotein cholesterol esters in rabbits. J Clin Invest 1991;87:331-46
22. Rashid S, Barrett PH, Uffelman KD, et al. Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation. Arterioscler Thromb Vasc Biol 2002;22:483-7
23. Tato F, Vega GL, Grundy SM. Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Role of cholesterolester transfer protein and lecithin cholesteryl acyl transferase. Arterioscler Thromb Vasc Biol 1997;17:56-63
24. Witztum JL, Dillingham MA, Giese W, et al. Normalization on triglycerides in type IV hyperlipoproteinemia fails to correct low levels of high-density-lipoprotein cholesterol. New Engl J Med 1980;303:907-14
25. Falko JM, Witztum JL, Schonfeld G, Bateman J. Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterol. Ann Intern Med 1979;91:750-1
26. Le Goff W, Guerin M, Chapman MJ. Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia. Pharmacol Ther 2004;101:17-38
27. Ferrieres J, Ruidavets JB, Perret B, et al. Prevalence of dyslipidaemias in a representative sample of the French population. Arch Mal Coeur Vaiss 2005;98:127-32
28. Schlienger JL, Simon C, Aby MA, et al. Lipid profile in adult population representative of a French district (Bas-Rhin). Pathol Biol (Paris) 1991;39:195-9
29. Godsland IF. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril 2001;75:898-915
30. Heitmann BL. The effects of gender and age on associations between blood lipid levels and obesity in Danish men and women aged 35-65 years. J Clin Epidemiol 1992;45:693-702
31. Abbott RD, Garrison RJ, Wilson PW, et al. Joint distribution of lipoprotein cholesterol classes. The Framingham study. Arteriosclerosis 1983;3:260-72
32. Laurenzi M, Mancini M. Plasma lipids in elderly men and women. Eur Heart J 1988;9(Suppl D):69-74
33. Ettinger WH, Wahl PW, Kuller LH, et al. Lipoprotein lipids in older people. Results from the Cardiovascular Health Study [The CHS Collaborative Research Group]. Circulation 1992;86:858-69
34. Ferrara A, Barrett-Connor E, Shan J. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. Circulation 1997;96:37-43
35. Bruckert E, Czernichow S, Bertrais S, et al. Blood lipid and lipoprotein levels: relationships with educational level and region of residence in the French SU.VI.MAX study. Prev Med 2005;40:803-11
36. Rimm EB, Williams P, Fosher K, et al. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. Br Med J 1999;319:1523-8
37. Sijbrands EJ, Smelt AH. Alcohol consumption had no beneficial effect on serum lipids in a substantial proportion of patients with primary hyperlipidemia. J Clin Epidemiol 2000;53:1020-4
38. Savolainen MJ, Kesaniemi YA. Effects of alcohol on lipoproteins in relation to coronary heart disease. Curr Opin Lipidol 1995;6:243-50
39. Hannuksela M, Marcel YL, Kesaniemi YA, Savolainen MJ. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 1992;33:737-44
40. Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000;102:179-84
41. Khovidhunkit W, Kim MS, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004;45:1169-96
42. Sampietro T, Bigazzi F, Dal Pino B, et al. Increased plasma C-reactive protein in familial hypoalphalipoproteinemia: a proinflammatory condition? Circulation 2002;105:11-4
43. Barter PJ, Nicholls S, Rye KA, et al. Antiinflammatory properties of HDL. Circ Res 2004;95:764-72
44. Laakso M, Sarlund H, Mykkanen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 1990;10:223-31
45. Nie L, Wang J, Clark LT, et al. Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J Lipid Res 1998;39:1127-30
46. Maclean PS, Tanner CJ, Houmard JA, Barakat HA. Plasma cholesteryl ester transfer protein activity is not linked to insulin sensitivity. Metabolism 2001;50:783-8
47. Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 2005;36:232-40
48. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46:459-69
49. Zietz B, Herfarth H, Paul G, et al. Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett 2003;545:103-4
50. Despres JP, Golay A, Sjostrom L. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. New Engl J Med 2005;353:2121-34
51. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J 1989;298:784-8
52. Dwyer JH, Rieger-Ndakorerwa GE, Semmer NK, et al. Low-level cigarette smoking and longitudinal change in serum cholesterol among adolescents. The Berlin-Bremen Study. J Am Med Assoc 1988;259:2857-62
53. Borggreve SE, Hillege HL, Wolffenbuttel BH, et al. The effect of cholesteryl ester transfer protein -629C→A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides. J Clin Endocrinol Metab 2005;90:4198-204
54. Chapman MJ, Assmann G, Fruchart JC, et al. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid - a position paper developed by the European Consensus Panel on HDL-C. Curr Med Res Opin 2004;20:1253-68
55. Couillard C, Despres JP, Lamarche B, et al. Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol 2001;21:1226-32
56. Williams PT, Wood PD, Krauss RM, et al. Does weight loss cause the exercise-induced increase in plasma high density lipoproteins? Atherosclerosis 1983;47:173-85